Cancer Screening and Prevention Program for High Risk Women

CompletedOBSERVATIONAL
Enrollment

1,452

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Ovarian CancerBreast Cancer
Trial Locations (3)

10016

Bellevue Hospital, New York

NYU Cancer Center, New York

NYU Tisch Hospital, New York

All Listed Sponsors
collaborator

Lynne Cohen Foundation for Ovarian Cancer Research

OTHER

lead

NYU Langone Health

OTHER

NCT00849199 - Cancer Screening and Prevention Program for High Risk Women | Biotech Hunter | Biotech Hunter